labetalol , a combined alpha- and beta-receptor antagonist , was compared with nifedipine in a placebo-controlled , randomized double-blind cross over study ( four week treatment periods ) of 11 normotensive patients with stable exertional angina pectoris .
C0028066
nifedipine
C0340288
stable